Sort by
Search results
BIOPHEN Factor XIII
Measurement of Factor XIII activity in human citrated plasma.
BIOPHEN Factor XIa
Assay proposed for the measurement of factor XIa activity in research applications.
BIOPHEN Heparin (AT+)
Assay proposed for the measurement of heparin in research applications.
BIOPHEN Heparin (anti-Xa, 2-stages kit) -> SEE NEW REF. 221005
Assay proposed for the measurement of anti-Xa heparin activity in research applications. This assay meets USP/EP requirements.
BIOPHEN Heparin 3
Measuring the heparin concentration in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin 6
Measuring the heparin concentration in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 3 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra ® , Orgaran ® , rivaroxaban (Xarelto ® ), apixaban (Eliquis ® ) and edoxaban (Lixiana ® ) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra ® , Orgaran ® , rivaroxaban (Xarelto ® ), apixaban (Eliquis ® ) and edoxaban (Lixiana ® ) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 7.5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra ® , Orgaran ® , rivaroxaban (Xarelto ® ), apixaban (Eliquis ® ) and edoxaban (Lixiana ® ) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin anti-IIa (2-stages kit)
Assay proposed for the measurement of heparin anti-thrombin activity in research applications acc. to Pharmacopoeia.